IMMUTOL
Sara presented her work on the development of an advanced cell therapy based on antigen-specific tolerogenic dendritic cells (TolDCs) to re-establish immune tolerance in immune-mediated diseases. Event website
read more
The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper…
read more
EMSP is the umbrella organization for national Multiple Sclerosis (MS) organizations in Europe and has been the leading voice for people with MS for over 30 years. EMSP works with members, partners, and…
read more
IMMUTOL coordinator, Silvia Gregori (FTELE/OSR) gave a talk at the 10th International Conference on HLA-G, 7-8 July 2025 in Ferrara, Italy about her work on IL-10-induced human tolerogenic DC: discussing their biology…
read more
15th Società Italiana di Immunologia, Immunologia Clinica e Allergologia (SIICA 2025) in Perugia, Italy, 17-18 June 2025 Silvia Gregori (FTELE/OSR), presented her work on latest advances in the development of engineered…
read more
The 2nd Annual Meeting of IMMUTOL consortium took place in Budapest between the 27th and 28th of May, 2025 hosted by SRI and organised by INN-Acta. The first day of the event was…
read more
Alex Agundez-Moreno (IGTP) participated in the 45th National Congress of the Spanish Society of Immunology (Sociedad Española de Inmunología (SEI)), which took place in Santander, Spain, from May 22 to…
read more
Silvia Gregori (FTELE/OSR) gave a talk entitled ‘Engineered IL-10-producing dendritic cells for cell-based approaches to restore tolerance’ at the EFI 2025 (38th European Immunogenetics & Histocompatibility Conference) 14-17 May 2025,…
read more
IMMUTOL was represented at the XLI congresso della Sezione Toscana SIAAIC 2025, 12-13 December 2025, Florence, where Silvia Gregori (FTELE/OSR) talked about the present and future of research in the…
read more